辅助生殖中的早产:妊娠期高血压疾病的中介作用
基于北欧三国注册队列的介质分析显示,冻融胚胎移植后早产风险高于自然妊娠,妊娠期高血压疾病可解释其中20.7%的关联;新鲜胚胎移植后早产风险亦升高,但妊娠期高血压疾病几乎不介导该关联。
要点
- 冻融胚胎移植后早产发生率6.6%,自然妊娠5.0%,总效应OR 1.29(95%CI 1.21-1.37),妊娠期高血压疾病介导20.7%。
- 新鲜胚胎移植后早产发生率8.1%,自然妊娠5.0%,总效应OR 1.49(95%CI 1.45-1.53),妊娠期高血压疾病介导比例仅0.5%。
- 中介效应主要见于医学指征性早产;敏感性分析及ART操作差异不改变主要结果。
核心结论
- 妊娠期高血压疾病不贡献于新鲜胚胎移植后早产风险的升高,但介导了冻融胚胎移植与早产之间20.7%的关联。
研究设计与样本
- 基于注册的队列研究,纳入丹麦(1994-2014)、挪威(1988-2015)和瑞典(1988-2015)北欧ART与安全委员会(CoNARTaS)队列的单胎妊娠。
- 分析纳入新鲜胚胎移植后单胎78 300例、冻融胚胎移植后单胎18 037例、自然妊娠单胎4 426 682例。
- 纳入标准为单胎妊娠、分娩时母亲年龄≥20岁、产次1-4次;采用logistic回归估计OR及95%CI,并分解总效应为直接与间接效应以估计中介比例。
主要发现
- 冻融胚胎移植后任何早产发生率6.6%,自然妊娠5.0%,总效应OR 1.29(95%CI 1.21-1.37),妊娠期高血压疾病介导效应OR 1.05(95%CI 1.04-1.05),中介比例20.7%。
- 新鲜胚胎移植后任何早产发生率8.1%,自然妊娠5.0%,总效应OR 1.49(95%CI 1.45-1.53),妊娠期高血压疾病介导效应OR 1.00(95%CI 1.00-1.00),中介比例0.5%。
- 中介效应主要见于医学指征性早产;额外调整体重指数和吸烟的敏感性分析及限制于初产妇的分析与主要结果一致,结果不受ART操作差异(卵胞浆内单精子注射、培养时长或移植胚胎数)驱动。
局限性
- 虽然可调整部分重要混杂因素,但不能排除残余混杂,尤其是与不孕相关的因素。
- 作者指出,若因果关系成立,可能有必要研究冻融胚胎移植后妊娠预防性使用阿司匹林等预防策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: To what extent can hypertensive disorders in pregnancy (HDP) explain the higher risk of preterm birth following frozen embryo transfer (frozen-ET) and fresh embryo transfer (fresh-ET) in ART compared with naturally conceived pregnancies? SUMMARY ANSWER: HDP did not contribute to the higher risk of preterm birth in pregnancies after fresh-ET but mediated 20.7% of the association between frozen-ET and preterm birth. WHAT IS KNOWN ALREADY: Risk of preterm birth is higher after ART compared to natural conception. However, there is also a higher risk of HDP in pregnancies after ART compared to natural conception, in particular after frozen-ET. HDP increases the risk of both spontaneous and medically indicated preterm birth. It is not known to what extent the higher risk of preterm birth in ART-conceived pregnancies is mediated through HDP. STUDY DESIGN, SIZE, DURATION: This registry-based cohort study included singleton pregnancies from the Committee of Nordic ART and Safety (CoNARTaS) cohort from Denmark (1994-2014), Norway (1988-2015), and Sweden (1988-2015). The analysis included 78 300 singletons born after fresh-ET, 18 037 after frozen-ET, and 4 426 682 after natural conception. The exposure was ART conception with either frozen-ET or fresh-ET versus natural conception. The main mediator of interest was any of the following HDP: gestational hypertension, preeclampsia, eclampsia, or chronic hypertension with superimposed preeclampsia. The main outcome was any preterm birth, defined as delivery <37 weeks of gestation. Secondary outcomes were spontaneous and medically indicated preterm birth, and different severities of preterm birth based on the gestational age threshold. PARTICIPANTS/MATERIALS, SETTING, METHODS: We linked data from the national Medical Birth Registries, ART registries/databases, and the National Patient Registries in each country using the unique national identity number of the mother. Criteria for inclusion were singleton pregnancies with birth order 1-4 in women aged ≥20 years at delivery. We used logistic regression to estimate odds ratios (ORs) with 95% CIs of preterm birth and decomposed the total effect into direct and mediated (indirect) effects to estimate the proportion mediated by HDP. Main models included adjustment for the year of delivery, maternal age, parity, and country. MAIN RESULTS AND THE ROLE OF CHANCE: Pregnancies following frozen-ET had a higher risk of any preterm birth compared to natural conception (occurrence 6.6% vs 5.0%, total effect OR 1.29, 95% CI 1.21-1.37) and 20.7% of the association was mediated by HDP (mediated effect OR 1.05, 95% CI 1.04-1.05). The mediation occurred primarily in medically indicated preterm births. Pregnancies following fresh-ET also had a higher risk of any preterm birth compared to naturally conceived pregnancies (occurrence 8.1% vs 5.0%, total effect OR 1.49, 95% CI: 1.45-1.53), but none of this could be mediated by HDP (mediated effect OR 1.00, 95%CI 1.00-1.00, proportion mediated 0.5%). Sensitivity analyses with extra confounder adjustment for body mass index and smoking, and restriction to primiparous women, were consistent with our main findings. Furthermore, the results were not driven by differences in ART procedures (intracytoplasmic sperm injection, culture duration, or the number of embryos transferred). LIMITATIONS, REASONS FOR CAUTION: Although we could adjust for some important confounders, we cannot exclude residual confounding, particularly from factors associated with infertility. WIDER IMPLICATIONS OF THE FINDINGS: This population-based mediation analysis suggests that some of the higher risk of preterm birth after ART treatment may be explained by the higher risk of HDP after frozen-ET. If causality is established, investigations into preventive strategies such as prophylactic aspirin in pregnancies after frozen-ET may be warranted. STUDY FUNDING/COMPETING INTEREST(S): Funding was provided by NordForsk (project number: 71450), the Nordic Federation of Obstetrics and Gynaecology (project numbers NF13041, NF15058, NF16026, and NF17043), the Norwegian University of Science and Technology (project number 81850092), an ESHRE Grant for research in reproductive medicine (grant number 2022-2), and the Research Council of Norway's Centres of Excellence funding scheme (project number 262700). D.A.L.'s and A.E.'s contribution to this work was supported by the European Research Council under the European Union's Horizon 2020 research and innovation program (grant agreements No 101021566) and the UK Medical Research Council (MC_UU_00032/05). D.A.L. has received support from Roche Diagnostics and Medtronic Ltd for research unrelated to that presented here. Pinborg declares grants from Gedeon Richter, Ferring, Cryos, and Merck, consulting fees from IBSA, Ferring, Gedeon Richter, Cryos, and Merck, payments from Gedeon Richter, Ferring, Merck, and Organon,travel support from Gedeon Richter. All other authors declare no conflicts of interest related to this work. TRIAL REGISTRATION NUMBER: ISRCTN 35879.
引用
- Petersen SH, Åsvold BO, Lawlor DA, et al. Preterm birth in assisted reproduction: the mediating role of hypertensive disorders in pregnancy. Hum Reprod. 2025. PMID: 39656847. doi:10.1093/humrep/deae261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。